Literature DB >> 14567695

Kinetics of fibrinopeptide release by thrombin as a function of CaCl2 concentration: different susceptibility of FPA and FPB and evidence for a fibrinogen isoform-specific effect at physiological Ca2+ concentration.

Aldo Profumo1, Marco Turci, Gianluca Damonte, Fabio Ferri, Davide Magatti, Barbara Cardinali, Carla Cuniberti, Mattia Rocco.   

Abstract

The kinetics of release of fibrinopeptide A (FPA) and B (FPB) by thrombin were investigated on unfractionated fibrinogen samples as a function of CaCl(2) concentration. A 50 mM Tris, 104 mM NaCl, pH 7.4 (TBS) buffer, to which 1 mM EDTA-Na(2) (TBE) or 2.5 (TBC2.5), 14 (TBC14), and 30 mM CaCl(2) (TBC30) was alternatively added, was employed. The % FPA versus time curves were fitted with single stretched-exponential growth functions, where the stretch parameter beta likely reflects substrate polydispersity (beta = 1, monodisperse). For TBE, TBS, TBC14, and TBC30, we found beta approximately 1, with corresponding normalized rate constants (K(a)) of 3.8, 4.2, 2.7, and 1.9 x 10(-5) [(NIHu/L)s](-1). Surprisingly, in TBC2.5 we found beta = 0.69, with an "average" K(a) of 3.5 x 10(-5) [(NIHu/L)s](-1). This effect disappeared [beta = 0.97, K(a) = 2.7 x 10(-5) [(NIHu/L)s](-1)] with an increase in the ionic strength I to that of TBC30 with 186 mM NaCl (TBCaNa buffer). FPB releases were instead consistent with a nonstretched consecutive exponential growth function, except in TBC30 where some FPB appeared to be cleaved independently. Log-log plots of K(a) versus Ca(2+) concentration, Cl(-) concentration, or I showed a strong linear correlation with only the latter two except in TBCaNa, again suggesting specific effects of the physiological Ca(2+) concentration and I on FPA release. The corresponding K(b) plots showed instead that both total depletion and high Ca(2+) hampered FPB release. To further investigate the TBC2.5 beta = 0.69 effect, FG polydispersity was assessed by Western blot analyses. The thrombin-binding gamma'-chain isoform was approximately 4%, resulting in a bound:free thrombin ratio of approximately 25:75. With regard to the C-terminal ends of the Aalpha-chains, approximately 45% were either intact or lightly degraded, while the remaining approximately 55% were more degraded. Fitting the % FPA release data in TBC2.5 with a sum of two exponentials resulted in a faster component and a slower component (K(a1)/K(a2) approximately 6), with a ratio of approximately 48:52. While a role for the gamma'-chain isoform cannot be excluded, this good correlation with the C-terminal degradation of the Aalpha-chains suggests their calcium-dependent involvement in FPA release.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14567695     DOI: 10.1021/bi034411e

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Nanoscale probing reveals that reduced stiffness of clots from fibrinogen lacking 42 N-terminal Bbeta-chain residues is due to the formation of abnormal oligomers.

Authors:  Radwa H Abou-Saleh; Simon D Connell; Robert Harrand; Ramzi A Ajjan; Michael W Mosesson; D Alastair M Smith; Peter J Grant; Robert A S Ariëns
Journal:  Biophys J       Date:  2009-03-18       Impact factor: 4.033

Review 2.  Mechanisms of fibrin polymerization and clinical implications.

Authors:  John W Weisel; Rustem I Litvinov
Journal:  Blood       Date:  2013-01-10       Impact factor: 22.113

3.  Peptide-functionalized spherical polyelectrolyte nanobrushes for real-time sensing of protease activity.

Authors:  Bin-Cheng Yin; Min Zhang; Weihong Tan; Bang-Ce Ye
Journal:  Chembiochem       Date:  2010-03-01       Impact factor: 3.164

4.  Polyphosphate enhances fibrin clot structure.

Authors:  Stephanie A Smith; James H Morrissey
Journal:  Blood       Date:  2008-06-10       Impact factor: 22.113

5.  Hydrodynamic characterization of recombinant human fibrinogen species.

Authors:  Bertrand Raynal; Barbara Cardinali; Jos Grimbergen; Aldo Profumo; Susan T Lord; Patrick England; Mattia Rocco
Journal:  Thromb Res       Date:  2013-04-30       Impact factor: 3.944

6.  A new modified animal model of myosin-induced experimental autoimmune myositis enhanced by defibrase.

Authors:  Luo Wen-Jing; Pu Chuan-Qiang; Li Hong-Hua; Lu Xiang-Hui; Liu Jie-Xiao
Journal:  Arch Med Sci       Date:  2015-12-11       Impact factor: 3.318

7.  Buffers Strongly Modulate Fibrin Self-Assembly into Fibrous Networks.

Authors:  Nicholas A Kurniawan; Thomas H S van Kempen; Stijn Sonneveld; Tilaï T Rosalina; Bart E Vos; Karin A Jansen; Gerrit W M Peters; Frans N van de Vosse; Gijsje H Koenderink
Journal:  Langmuir       Date:  2017-06-13       Impact factor: 3.882

Review 8.  Biomaterials for the Delivery of Growth Factors and Other Therapeutic Agents in Tissue Engineering Approaches to Bone Regeneration.

Authors:  Christine J Kowalczewski; Justin M Saul
Journal:  Front Pharmacol       Date:  2018-05-29       Impact factor: 5.810

9.  Assessment of Migration of Human MSCs through Fibrin Hydrogels as a Tool for Formulation Optimisation.

Authors:  Nasseem Salam; Sotiria Toumpaniari; Piergiorgio Gentile; Ana Marina Ferreira; Kenneth Dalgarno; Simon Partridge
Journal:  Materials (Basel)       Date:  2018-09-19       Impact factor: 3.623

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.